go back

ASXL1 Gene Test for Bone Marrow Disorders

Vermont rates for HCPCS 81175

A laboratory test that examines the ASXL1 gene in a blood or bone marrow sample for changes associated with disorders of the bone marrow, including myelodysplastic syndromes and certain leukemias. Findings help confirm a diagnosis and give a sense of how the disease is likely to behave. Results are read alongside the blood counts, marrow findings, and other testing.

Rates data updated July 2026.

Facilitymedian $676 · 10th–90th $676$1,1220%20%40%90th$676Professionalmedian $871 · 10th–90th $490$8710%20%40%10th$871$500.0$1.0K$2.0K$5.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Professional
Modifier
Global
Typical Low
$489.78
Median
$870.96
Typical High
$870.96
Cigna
Setting
Facility
Modifier
Global
Typical Low
$1,122.02
Median
$1,122.02
Typical High
$1,122.02
Cigna
Setting
Professional
Modifier
Global
Typical Low
$346.74
Median
$831.76
Typical High
$1,071.52
MVP Health Care
Setting
Facility
Modifier
Global
Typical Low
$676.08
Median
$676.08
Typical High
$676.08
MVP Health Care
Setting
Professional
Modifier
Global
Typical Low
$676.08
Median
$676.08
Typical High
$707.95
United
Setting
Professional
Modifier
Global
Typical Low
$407.38
Median
$776.25
Typical High
$1,548.82